Knorr-Bremse Aktiengesellschaft: Dr. Jan Michael Mrosik appointed as Chairman of the Executive Board of Knorr-Bremse AG
DGAP-News: Knorr-Bremse Aktiengesellschaft
/ Key word(s): Personnel
Press Release Dr. Jan Michael Mrosik appointed as Chairman of the Executive Board of Knorr-Bremse AG München, November 4, 2020 - The Supervisory Board of Knorr-Bremse AG today unanimously appointed Dr. Jan Michael Mrosik (56) as Chairman of the Executive Board of Knorr-Bremse AG for a period of three years from January 1, 2021. "I am delighted that in Dr. Mrosik we have gained a highly experienced manager who has extensive expertise in the management of complex corporate units at Siemens", says Prof. Dr. Klaus Mangold, Chairman of the Supervisory Board of Knorr-Bremse AG. "In addition to his experience in strategic and operational management, Dr. Mrosik has a distinct expertise especially in the areas of automation and digitization. The Supervisory Board is convinced that Dr. Mrosik, together with the successful Knorr-Bremse Executive Board team, will lead the company into the future." Dr. Mrosik was most recently Chief Operating Officer of the Digital Industries (DI) division of Siemens AG with global sales of around EUR 16 billion and 76,000 employees. Dr. Mrosik studied at the RWTH Aachen University and holds a degree in electrical engineering. He received his doctorate in engineering from the same university. "I am very much looking forward to the new tasks at Knorr-Bremse. It is a great company with high strategic potential, both in rail and commercial vehicles. We have the best prerequisites to expand our market position globally. With my special experience I will drive forward the digitalization in particular", says Dr. Mrosik. The Supervisory Board also decided to extend the contract of Dr. Jürgen Wilder (50), member of the Executive Board of Knorr-Bremse AG since 2018 and responsible for the Rail Vehicle Systems division (RVS), early for five years with effect from September 1, 2021. "During his term of office to date, Dr. Wilder has made a major contribution to his division. With this decision, we are ensuring that Dr. Wilder will continue to actively translate the special challenges in the growth market of mobility into successful business models for Knorr-Bremse in the future. We look forward to continuing our collaboration with him", says Prof. Dr. Klaus Mangold. About Knorr-Bremse
04.11.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Knorr-Bremse Aktiengesellschaft |
Moosacher Str. 80 | |
80809 Munich | |
Germany | |
Phone: | +49 89 3547 0 |
E-mail: | info@knorr-bremse.com |
Internet: | www.knorr-bremse.com |
ISIN: | DE000KBX1006 |
WKN: | KBX100 |
Indices: | MDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange (Third Market (MTF)) |
EQS News ID: | 1145478 |
End of News | DGAP News Service |
|
1145478 04.11.2020